HIV Therapy: Addressing Unanswered Questions to Optimize Care
2.5 Credits / HIV/AIDS
View More
Exploring Primary Immunodeficiency Disorder Treatment: A Review of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin Therapies
1.0 Credit / Immunology, Neurology
View More
Over-the-Counter Treatment Paradigms for Pain Management: Adapting to the “New Normal”
1 Credit / Pain Management/Opioids
View More
Over-the-Counter Treatment Paradigms for Pain Management: Adapting to the “New Normal” (Technician Credit)
1 Credit / Pain Management/Opioids
View More
Influenza Vaccine Recommendations for the 2022-2023 Season: An Update for Pharmacists
1.5 Credits / Immunizations
View More
Advancements in Treatment Options for Age-Related Macular Degeneration and Diabetic Macular Edema, featuring a Patient Perspective
1.5 Credits / Ophthalmology/Optometry
View More
Targeting the Sickle Cell Disease Cascade and the Shifting Approach to Care
1.5 Credits / Hematology, Rare Diseases
View More
ROS1-Targeted Treatments in NSCLC: Updates and Best Practices for Managed Care
1.5 Credit(s) / Oncology
View More
NDA for Investigational Schizophrenia Treatment Submitted to FDA
The NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.
Nobel Prize Awarded to Scientists Whose mRNA Work Allowed Development of COVID-19 Vaccines
Katalin Karikó, PhD, and Drew Weissman, MD, PhD, were cited "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."
Older Women at Greatest Risk of C Diff, COVID-19 Coinfection
September 28th 2023Beyond female gender, comorbidities independently associated with C diff infection in patients diagnosed with COVID-19 included peptic ulcer disease, renal failure, weight loss, diabetes mellitus with complications, and congestive heart failure.
Opioid Use Disorder Medication Initiation After ED Visits for Overdose Remains Low
September 27th 2023A study from the University of Michigan found that only 1 in 6 emergency department visits for an opioid overdose in the United States result in a prescription for buprenorphine, methadone, or extended-release naltrexone.